Evidence map›Paper›PMID 39764298›Full record

ArticleJournal of physical therapy science2025

Relationship between physical function and quality of life based on treatment timing in patients with advanced lung cancer.

Norihiko Muraoka, Takanori Ro, Tetsuo Ota

Abstract read
In one paragraph

Article in Journal of physical therapy science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Norihiko MuraokaRehabilitation Unit, Asahikawa Medical University Hospital: 2-1-1-1 Midorigaokahigashi, Asahikawa-shi, Hokkaido 078-8510, Japan.
Takanori RoRehabilitation Unit, Asahikawa Medical University Hospital: 2-1-1-1 Midorigaokahigashi, Asahikawa-shi, Hokkaido 078-8510, Japan.
Tetsuo OtaRehabilitation Unit, Asahikawa Medical University Hospital: 2-1-1-1 Midorigaokahigashi, Asahikawa-shi, Hokkaido 078-8510, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

[Purpose] Rehabilitation can improve physical function and quality of life in patients with advanced cancer. However, relevant studies on advanced lung cancers are limited. Differences in physical function and symptoms based on the treatment phase should be considered. This study investigated the relationship between physical function and quality of life during the treatment phase in patients with advanced lung cancer. [Participants and Methods] Patients with stage IV non-small-cell lung cancer and postoperative recurrence who were hospitalized between May 2018 and October 2021 were selected. Data, including age, histological type of lung cancer, treatment details, functional independence measures, and European Organization for Research and Treatment of Cancer QLQ-C30, were collected from medical records. Patients were categorized into groups based on the treatment phase: the initial, subsequent, and best supportive care (BSC) groups comprised patients admitted for initial treatment, receiving second or subsequent treatments, and receiving best supportive care, respectively. The relationship between physical function and quality of life during each treatment phase was examined. [Results] Physical function in the subsequent group was associated with physical functioning, role functioning, cognitive functioning, social functioning, and fatigue. Meanwhile, the BSC group had fewer associated items than the other groups. [Conclusion] Rehabilitation during the ongoing treatment phase improves physical function and quality of life.

Indexed as

Advanced lung cancerPhysical functionQuality of life

Identifiers

PMID39764298
PMCPMC11700573

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.